method of forecasting the risk of development of secondary anemia severe degree, requiring the u0433u0435u043cu043eu0442u0440u0430u043du0441u0444u0443u0437u0438u0438, in the first half year of life in childrenafter u0432u043du0443u0442u0440u0438u0443u0442u0440u043eu0431u043du043eu0435 blood transfusion on the hemolytic disease of the fetus on the rhesus factor

摘要

FIELD: medicine.;SUBSTANCE: invention is a method for prediction of severe secondary anemia development, requiring blood transfusion, in young infants undergoing intrauterine transfusion (IUT) because of fetal hemolytic disease on the rhesus factor (HDN), which includes determination of the level of venous blood hematocrit at birth (A₁), determination of the average level of erythrocyte in venous blood on day 14-21 of life (A₂) calculation of the prognostic index (D) by the formula D=A₁×0.529-A₂×0.221+3.256 and prediction of a high risk of secondary anemia when D≥0, or prediction of the absence of secondary anemia when D0.;EFFECT: method allows to allocate a risk group in terms of severe anemia development at the out-patient stage, in the neonatality period children with fetal hemolytic disease on the rhesus factor after prenatal intrauterine blood transfusion, which gives an opportunity to prevent the development of this state and narrow the range of children, requiring frequent study of hemogram.;2 ex